Abruptio placentae associated with misoprostol use in women with preeclampsia

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 50, Issue 9, 2005, Pages 653-658

  Fontenot, M Todd ^a   Lewis, David F ^a   Barton, C Brent ^a   Jones, Elizabeth M ^a   Moore, Jodi A ^a   Evans, Arthur T ^a  

^a NONE

Author keywords

Abruptio placentae; Misoprostol; Preeclampsia

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN E2;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DRUG IMPLANT; EMERGENCY SURGERY; FEMALE; FETUS DISTRESS; FETUS HEART RATE; HUMAN; INCIDENCE; LABOR COMPLICATION; LABOR INDUCTION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SOLUTIO PLACENTAE; UTERINE CERVIX RIPENING; UTERUS CONTRACTION; UTERUS HYPERSTIMULATION;

EID: 25444444799     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Sibai BM, Caritis S, Hauth J, et al: What we have learned about preeclampsia. Semin Perinatol 2003;27:239-246
2. Hauth JC, Ewell MG, Levine RJ, et al: Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol 2000;95:24-28
3. Cunningham FG, Gant NF, Leveno KJ, et al: Hypertensive disorders in pregnancy. In Williams Obstetrics. Twenty-first edition. New York, McGraw-Hill, 2001, pp 567-618
4. 2 Insert Study Group. J Matern Fetal Med 1996;5:64-69
5. Crane JM, Bennett KA: A meta-analysis of controlled-release prostaglandin for cervical ripening and labour induction. J Soc Obstet Gynecol Can 2000;22:692-698
6. Hughes EG, Kelly AJ, Kavanagh J: Dinoprostone vaginal insert for cervical ripening and labor induction: A meta-analysis. Obstet Gynecol 2001;97:847-855
7. Sanchez-Ramos L, Kaunitz AM, Delke I, et al: Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: A meta-analysis. Obstet Gynecol 1999; 94:878-883
8. Ananth CV, Smulian JC, Demissie K, et al: Placental abruption among singleton and twin births in the United States: Risk factor profiles. Am J Epidemiol 2001;153:771-778
9. Cunningham FG, Gant NF, Leveno KJ, et al: Obstetrical hemorrhage. In Williams Obstetrics. Twenty-first edition. New York, McGraw-Hill, 2001, pp 619-669
10. Kramer MS, Usher RH, Pollack R, et al: Etiologic determinants of abruptio placentae. Obstet Gynecol 1997;89:221-226
11. Buchbinder A, Sibai BM, Caritis S, et al: Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002;186:66-71
12. Sibai BM, Lindheimer M, Hauth J, et al: Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998;339:667-671
13. Sibai BM, Mercer BM, Schiff E, et al: Aggressive versus expectant management of severe preeclampsia at 28-32 weeks gestation: A randomized controlled trial. Am J Obstet Gynecol 1994; 171:818-822
14. Carlan SJ, Bouldin S, Blust D, et al: Safety and efficacy of misoprostol orally and vaginally: A randomized trial. Obstet Gynecol 2001;98:107-112
15. How HY, Leasegurge L, Khoury JC, et al: A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. Am J Obstet Gynecol 2001;185:911-915
16. Lyrenas S, Clason I, Ulmsten U: In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. Br J Obstet Gynaecol 2001;108:167-178
17. Cervidil® brand of dinoprostone vaginal insert. In Physicians' Desk Reference. Fifty-eighth edition. Edited by H Fleming, L Murray, GL Kelly, et al. Montvale, NJ, Medical Economics, 2004, pp 1296-1297
18. Goldberg AB, Greenberg MB, Darney PD: Misoprostol and pregnancy. N Engl J Med 2001;334:38-47
19. Cytotec® misoprostol tablets. In Physicians' Desk Reference. Fifty-eighth edition. Edited by H Fleming, L Murray, GL Kelly, et al. Montvale, NJ, Medical Economics, 2004, pp 3109-3111
20. Agarwal N, Gupta A, Kriplani A, et al: Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction. J Obstet Gynaecol Res 2003;29:147-151
21. Lokugamage AU, Forsyth SF, Sullivan KR, et al: Dinoprostone versus misoprostol: A randomized study of nulliparous women undergoing induction of labor. Acta Obstet Gynecol Scand 2003;82:133-137
22. Garry D, Figueroa R, Kalish RB, et al: Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor induction. J Matern Fetal Neonatal Med 2003;13:254-259
23. Chang YK, Chen WH, Yu MH, et al: Intracervical misoprostol and prostaglandin E2 for labor induction. Int J Gynaecol Obstet 2003;80:23-28
24. Neiger R, Greaves PC: Comparison between vaginal misoprostol and cervical dinoprostone for cervical ripening and labor induction. Tenn Med 2001;94:25-27
25. Wing DA, Rahall A, Jones MM, et al: Misoprostol: An effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995;172:1811-1816
26. 1 misoprostol compared with dinoprostone vaginal insert: A randomized trial. Obstet Gynecol 1998;91:401-405
27. Dallenbach P, Boulvain M, Viardot C, et al: Oral misoprostol or vaginal dinoprostone for labor induction: A randomized controlled trial. Am J Obstet Gynecol 2003;188:162-167
28. Hofmeyr GJ, Gulmezoglu AM: Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2003;1:CD000941
29. Sanchez-Ramos L, Kaunitz AM, Wears RL, et al: Misoprostol for cervical ripening and labor induction: A meta-analysis. Obstet Gynecol 1997;89:633-642
30. Buser D, Mora G, Arias F: A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices. Obstet Gynecol 1997;89:581-585
31. Wing DA, Ortiz-Omphroy G, Paul RH: A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol 1997;177:612-618
32. Wing DA, Park MR, Paul RH: A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstet Gynecol 2000;95:905-908
33. Ramsey PS, Harris DY, Ogburn PL Jr, et al: Comparative efficacy and cost of the prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents. Am J Obstet Gynecol 2003;188:560-565
34. Sanchez-Ramos L, Kaunitz AM, Delke I: Labor induction with 25 μg versus 50 μg intravaginal misoprostol: A systematic review. Obstet Gynecol 2002;99:145-151
35. Magtibay PM, Ramin KD, Harris DY, et al: Misoprostol as a labor induction agent. J Matern Fetal Med 1998;7:15-18
36. Sanchez-Ramos L, Chen AH, Kaunitz AM, et al: Labor induction with intravaginal misoprostol in term premature rupture of membranes: A randomized study. Obstet Gynecol 1997;89:909-912
37. Khoury AN, Zhou Q-P, Gorenberg DM, et al: A comparison of intermittent vaginal administration of two different doses of misoprostol suppositories with continuous dinoprostone for cervical ripening and labor induction. J Matern Fetal Med 2001;10:186-192
38. Ferguson JA, Head BH, Frank FH, et al: Misoprostol versus low-dose oxytocin for cervical ripening: A prospective, randomized, double-masked trial. Am J Obstet Gynecol 2002;187:273-279
39. Rowlands S, Bell R, Donath S, et al: Misoprostol versus dinoprostone for cervical priming prior to induction of labour in term pregnancy: A randomised controlled trial. Aust N Z J Obstet Gynaecol 2001;41:145-152
40. Has R, Batukan C, Ermis H, et al: Comparison of 25 and 50 μg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecol Obstet Invest 2002;53:16-21
41. Adair CD, Weeks JW, Barrilleaux S, et al: Oral or vaginal misoprostol administration for induction of labor: A randomized, double-blind trial. Obstet Gynecol 1998;92:810-813
42. Carlan SJ, Blust D, O'Brien WF: Buccal versus intravaginal misoprostol administration for cervical ripening. Am J Obstet Gynecol 2002;186:229-233
43. Zieman M, Fong SK, Benowitz NL, et al: Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92
44. Danielsson KG, Marions L, Rodriguez A, et al: Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93:275-280
45. Wing DA, Paul RH: A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1996;175:158-164